Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8884884 | 0.94 | CA14 (0.35) | CA1CA12CA14CA7TDP1 | |
| SCHEMBL991812 | 0.90 | CA14 (0.38) | CA1CA12CA14CA7TDP1 | |
| SCHEMBL30981829 | 0.87 | TDP1 (0.43) | CA1CA12CA14CA7TDP1 | |
| SCHEMBL5846389 | 0.86 | CA14 (0.33) | CA1CA12CA14CA7TDP1 | |
| SCHEMBL28495713 | 0.86 | TDP1 (0.45) | CA1CA12CA14CA7TDP1 | |
| SCHEMBL2905982 | 0.84 | MEN1 (0.33) | CA1CA12CA14CA7TDP1 | |
| SCHEMBL3488586 | 0.84 | TDP1 (0.48) | CA1CA12CA14CA7TDP1 | |
| SCHEMBL28323963 | 0.84 | TDP1 (0.51) | CA1CA12CA14TDP1CA2 | |
| SCHEMBL8886749 | 0.84 | TDP1 (0.48) | CA1CA12CA14CA7TDP1 | |
| SCHEMBL29850083 | 0.84 | TDP1 (0.38) | CA1CA12CA14CA7TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5627194-A | FOR TREATING HERPES VIRUS INFECTIONS | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1997-05-06 | — | — | US | disclosed |